Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01037270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271
Last updated 2013-02-11
Summary
This is a multi-center study designed to evaluate the accuracy and precision of the INRatio® Prothrombin Time (PT) Monitoring System, utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity, when used by trained medical professionals for the quantitative determination of PT and International Normalized Ratio (INR) in fingerstick and venous whole blood from subjects on oral anticoagulation therapy (OAT). These results will be compared to those PT/INR results obtained on plasma from the same subjects as analyzed at a central laboratory with the Sysmex CA-560 System.
Conditions
- Pulmonary Embolism
- Atrial Fibrillation
- Deep Vein Thrombosis
Sponsors & Collaborators
-
Abbott RDx Cardiometabolic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Blood Donation From Warfarin Users for the Development of POC INR Monitor
NCT02355730 ·Status: UNKNOWN ·Phase: NA
-
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System
NCT00978445 ·Status: COMPLETED ·Phase: NA
-
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
NCT01930916 ·Status: UNKNOWN ·Phase: NA
-
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
NCT00703963 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
NCT00123734 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
NCT03682419 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test
NCT04074980 ·Status: COMPLETED ·Phase: NA
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
NCT02371070 ·Status: COMPLETED
-
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
NCT00291330 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries.
NCT04608591 ·Status: UNKNOWN
-
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
NCT01729559 ·Status: COMPLETED ·Phase: PHASE4
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Inpatient Monitoring of Unfractionated Heparin
NCT06329921 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Inhibitors of the Proton Pump on Intestinal Transporters
NCT02524210 ·Status: COMPLETED ·Phase: PHASE1
-
PT/INR Reference Interval IN Healthy Volunteers
NCT02319109 ·Status: COMPLETED
-
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.
NCT06066762 ·Status: UNKNOWN
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
NCT01828697 ·Status: COMPLETED ·Phase: PHASE4
-
Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
NCT00878137 ·Status: COMPLETED
-
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
NCT04539301 ·Status: RECRUITING
-
The Home INR Study
NCT00032591 ·Status: COMPLETED ·Phase: PHASE4
-
Low Dose Heparin Factorial Trial
NCT05591872 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
NCT02562690 ·Status: UNKNOWN